News on Urocare Products Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Urocare Products Inc news from BioPortfolio.com Tue, 09 Feb 2010 22:26:50 GMT en SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products For Distribution Across Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034087&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034087&THISHREF=http://c.moreover.com/click/here.pl%3fz2535616533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034087&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034087&THISHREF=http://c.moreover.com/click/here.pl%3fz2535616533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Evolution Fuels Executes Lease for Arkansas Truck Stophttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035457&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035457&THISHREF=http://c.moreover.com/click/here.pl%3fz2536251445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035457&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035457&THISHREF=http://c.moreover.com/click/here.pl%3fz2536251445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Air Products Offers to Acquire Airgas for $60.00 Per Share in Cashhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035060&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035060&THISHREF=http://c.moreover.com/click/here.pl%3fz2536105142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035060&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035060&THISHREF=http://c.moreover.com/click/here.pl%3fz2536105142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comChemie.de: Tempo announced as new Canadian distributor for Colonialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032838&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032838&THISHREF=http://c.moreover.com/click/here.pl%3fz2534832560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032838&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032838&THISHREF=http://c.moreover.com/click/here.pl%3fz2534832560%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comChemie.de: Transcept Pharmaceuticals Granted First U.S. Patent Coveringhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038038&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038038&THISHREF=http://c.moreover.com/click/here.pl%3fz2537450604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038038&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038038&THISHREF=http://c.moreover.com/click/here.pl%3fz2537450604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via MSN Money: Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Therapy (OTC:SCII)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035374&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035374&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035374&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035374&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Therapy (OTC:SCII)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033946&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033946&THISHREF=http://c.moreover.com/click/here.pl%3fz2535503936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033946&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033946&THISHREF=http://c.moreover.com/click/here.pl%3fz2535503936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Chronicle: Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Stock Repurchase Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032740&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032740&THISHREF=http://c.moreover.com/click/here.pl%3fz2534793108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032740&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032740&THISHREF=http://c.moreover.com/click/here.pl%3fz2534793108%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038114&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038114&THISHREF=http://c.moreover.com/click/here.pl%3fz2537475647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038114&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038114&THISHREF=http://c.moreover.com/click/here.pl%3fz2537475647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038043&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038043&THISHREF=http://c.moreover.com/click/here.pl%3fz2537453712%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038043&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038043&THISHREF=http://c.moreover.com/click/here.pl%3fz2537453712%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038031&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038031&THISHREF=http://c.moreover.com/click/here.pl%3fz2537444828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038031&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038031&THISHREF=http://c.moreover.com/click/here.pl%3fz2537444828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038003&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038003&THISHREF=http://c.moreover.com/click/here.pl%3fz2537422738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038003&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038003&THISHREF=http://c.moreover.com/click/here.pl%3fz2537422738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038001&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537421042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038001&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537421042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038000&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038000&THISHREF=http://c.moreover.com/click/here.pl%3fz2537420673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038000&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038000&THISHREF=http://c.moreover.com/click/here.pl%3fz2537420673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037995&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037995&THISHREF=http://c.moreover.com/click/here.pl%3fz2537419178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037995&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Urocare%20Products%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037995&THISHREF=http://c.moreover.com/click/here.pl%3fz2537419178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: